HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhito Kawata Selected Research

Kazuhito Kawata Research Topics

Disease

21Hepatocellular Carcinoma (Hepatoma)
10/2022 - 02/2011
8Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2021 - 08/2010
5Neoplasms (Cancer)
01/2022 - 01/2018
5Cholangitis
09/2013 - 10/2012
4Infections
01/2022 - 12/2015
3Fibrosis (Cirrhosis)
03/2022 - 07/2020
3Neoplasm Metastasis (Metastasis)
01/2022 - 01/2018
3Chronic Hepatitis C
01/2022 - 01/2014
3Liver Neoplasms (Liver Cancer)
08/2021 - 01/2021
3Pancreatitis
07/2021 - 01/2017
2Fatigue
06/2022 - 03/2022
2Ascites
05/2022 - 04/2021
2Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2013
2Hemorrhage
04/2021 - 02/2011
2Liver Diseases (Liver Disease)
01/2021 - 12/2012
2Non-alcoholic Fatty Liver Disease
01/2021 - 01/2014
2Inflammation (Inflammations)
01/2021 - 10/2012
2Colitis
03/2013 - 10/2012
1Carcinoma (Carcinomatosis)
09/2022
1Diarrhea
06/2022
1Hypothyroidism
06/2022
1Edema (Dropsy)
05/2022
1Hypertension (High Blood Pressure)
03/2022
1Urinary Tract Infections (Urinary Tract Infection)
01/2022
1Alopecia (Baldness)
08/2021
1Oral Ulcer (Mouth Ulcer)
08/2021
1Autoimmune Hepatitis
08/2021
1Sarcopenia
07/2021
1Disease Progression
07/2021
1Immunoglobulin Light-chain Amyloidosis
02/2021
1Hepatomegaly
02/2021
1Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
02/2021
1Amyloidosis
02/2021
1Alcoholic Fatty Liver
01/2021
1Chronic Kidney Failure (Chronic Renal Failure)
07/2020
1Diabetic Nephropathies (Diabetic Nephropathy)
07/2020
1T-Cell Lymphoma (Lymphoma, T Cell)
08/2018
1Multiple Myeloma
01/2018
1Obstructive Jaundice (Cholestatic Jaundice)
01/2018
1Pathologic Constriction (Stenosis)
01/2018

Drug/Important Bio-Agent (IBA)

14lenvatinibIBA
06/2022 - 01/2020
7Bevacizumab (Avastin)FDA Link
10/2022 - 01/2022
7atezolizumabIBA
10/2022 - 01/2022
5Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2021 - 08/2010
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2022 - 01/2014
4AlbuminsIBA
01/2022 - 01/2021
3C-Reactive ProteinIBA
10/2022 - 01/2022
3Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2022
3Antiviral Agents (Antivirals)IBA
03/2022 - 12/2020
3BilirubinIBA
01/2022 - 01/2021
3CytokinesIBA
03/2013 - 10/2012
2velpatasvirIBA
03/2022 - 12/2020
2SofosbuvirIBA
03/2022 - 12/2020
2Prednisolone (Predate)FDA LinkGeneric
08/2018 - 06/2010
2Transforming Growth Factors (Transforming Growth Factor)IBA
11/2017 - 02/2013
2EnzymesIBA
04/2013 - 06/2010
2InterleukinsIBA
02/2013 - 10/2012
2Interleukin-12 (IL 12)IBA
01/2013 - 10/2012
1Urea (Carbamide)FDA LinkGeneric
05/2022
1Polysaccharides (Glycans)IBA
01/2022
1Hair DyesIBA
01/2022
1Serum AlbuminIBA
08/2021
1Sorafenib (BAY 43-9006)FDA Link
08/2021
1regorafenibIBA
08/2021
1Azathioprine (Imuran)FDA LinkGeneric
08/2021
1RamucirumabIBA
04/2021
1Apolipoprotein A-I (Apolipoprotein A1)IBA
02/2021
1Amyloid (Amyloid Fibrils)IBA
02/2021
1Prealbumin (Transthyretin)IBA
02/2021
1LigandsIBA
01/2021
1ChemokinesIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Fetal Proteins (Fetoprotein)IBA
01/2021
1Phosphotransferases (Kinase)IBA
07/2020
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2020
1MineralsIBA
07/2020
1CC ChemokinesIBA
07/2020
1Sodium-Glucose Transport ProteinsIBA
07/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
07/2020
1Pharmaceutical PreparationsIBA
07/2020
1Glucagon-Like Peptide 1 (GLP 1)IBA
07/2020
1Sodium-Glucose Transporter 2 InhibitorsIBA
07/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1BezafibrateIBA
12/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2018
1Etoposide (VP 16)FDA LinkGeneric
08/2018
1Procarbazine (Matulane)FDA Link
08/2018
1LipidsIBA
03/2018
1PlasticsIBA
01/2018
1Immunoglobulin D (IgD)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
11/2017

Therapy/Procedure

11Therapeutics
06/2022 - 06/2010
2Radiotherapy
01/2018 - 02/2011
1Immunotherapy
10/2022
1Bathroom Equipment
01/2022
1Cesarean Section (Caesarean Section)
01/2022
1Self Expandable Metallic Stents
07/2021
1Liver Transplantation
07/2020
1Drug Therapy (Chemotherapy)
01/2020
1Stents
01/2018